Thomas Ruby
Impact in
- Endocrinology top 5%
- Vibrio bacteria research studies
- Immunology top 5%
- Immune Response and Inflammation
- interferon and immune responses
- Immune Cell Function and Interaction
Papers in
-
- Gut microbiota and health 2
- Peroxisome Proliferator-Activated Receptors 1
-
- interferon and immune responses 2
- Immune cells in cancer 1
- Co-authors
- Denise M. Monack (5 shared papers)Nobuhiko Kayagaki (1 shared paper)Petr Brož (1 shared paper)Kamila Belhocine (1 shared paper)Vishva M. Dixit (1 shared paper)Donna M. Bouley (1 shared paper)Smita Gopinath (1 shared paper)Ajay Chawla (1 shared paper)
- Journals
- Immunogenetics (2 papers)FEMS Microbiology Reviews (1 paper)Journal of Virology (1 paper)Cell Host & Microbe (1 paper)The Journal of Immunology (1 paper)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Thomas Ruby
8 papers receiving 987 citations
Peers
Comparison fields: 5 of 85
- Endocrinology 143
- Immunology 440
- Food Science 158
- Molecular Biology 554
- Infectious Diseases 132
Countries citing papers authored by Thomas Ruby
This map shows the geographic impact of Thomas Ruby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Ruby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Ruby more than expected).
Fields of papers citing papers by Thomas Ruby
This network shows the impact of papers produced by Thomas Ruby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Ruby. The network helps show where Thomas Ruby may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Ruby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 447 | |
| 2 | 2013 | 172 | |
| 3 | 2010 | 131 | |
| 4 | 2012 | 130 | |
| 5 | 2006 | 53 | |
| 6 | 2005 | 30 | |
| 7 | 2008 | 18 | |
| 8 | 2011 | 17 |
About Thomas Ruby
Thomas Ruby is a scholar working on Molecular Biology, Immunology, Infectious Diseases, Virology and Animal Science and Zoology, having authored 8 papers that have together received 998 indexed citations. Recurring topics across this work include Gut microbiota and health (2 papers), Viral gastroenteritis research and epidemiology (2 papers), interferon and immune responses (2 papers), Salmonella and Campylobacter epidemiology (1 paper), Peroxisome Proliferator-Activated Receptors (1 paper), Immune cells in cancer (1 paper), Hepatitis Viruses Studies and Epidemiology (1 paper) and Virology and Viral Diseases (1 paper). The work is most often cited by research in Endocrinology (143 citations), Immunology (440 citations), Food Science (158 citations), Molecular Biology (554 citations) and Infectious Diseases (132 citations). Thomas Ruby has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Denise M. Monack, Nobuhiko Kayagaki, Petr Brož, Kamila Belhocine, Vishva M. Dixit, Donna M. Bouley, Smita Gopinath, Ajay Chawla, Lilian H. Lam and Nicholas A. Eisele. Their work appears in journals such as Immunogenetics, FEMS Microbiology Reviews, Journal of Virology, Cell Host & Microbe and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.